Literature DB >> 28501693

Necrostatin-1 protects hippocampal neurons against ischemia/reperfusion injury via the RIP3/DAXX signaling pathway in rats.

Rongli Yang1, Kun Hu1, Jieyun Chen1, Shiguang Zhu2, Lei Li1, Hailong Lu1, Pingjing Li1, Ruiguo Dong3.   

Abstract

Global cerebral ischemia/reperfusion (I/R) induces selective neuronal injury in CA1 region of hippocampus, leading to severe impairment in behavior, learning and memory functions. However, the molecular mechanism underlying the processes was not elucidated clearly. RIP3 is a key molecular switch connecting apoptosis, necrosis and necroptosis. DAXX, as a novel substrate of RIP3, plays a vital role in ischemia-induced neuronal death. The aim of this study is to investigate the role and mechanism of RIP3/DAXX signaling pathway on neurons in CA1 region of the rat hippocampus after cerebral I/R. Global cerebral ischemia was induced by the method of four-vessel occlusion. RIP1 specific inhibitor Necrostatin-1 was administered by intracerebroventricular injection 1h before ischemia. Open-field, closed-field, and Morris water maze tests were performed respectively to examine the anxiety and cognitive behavior in each group. Hematoxylin and eosinstaining was used to examine the survival of hippocampal CA1 pyramidal neurons. Western blot or immunoprecipitation were carried to detect protein expression, phosphorylation, and interaction. We found that pre-treatment with Nec-1 protected locomotive ability, relieved anxiety behavior, and improved cognitive ability in the rats subjected to cerebral I/R. In addition Moreover, Nec-1 decreased significantly the dead rate of neurons in hippocampal CA1 region after cerebral I/R through suppressing RIP1-RIP3 interaction and RIP3 activation along with RIP3-DAXX interaction, and then blocked DAXX translocation from nucleaus to cytoplasm, which resulted in the inactiviation of DAXX. We concluded that pre-treatment with Nec-1 can protect neurons in the hippocampal CA1 region against ischemic damage through the RIP3-DAXX signaling pathway.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Global cerebral ischemia/reperfusion; Necrostatin-1; Receptor-interacting protein 3; The death-associated protein

Mesh:

Substances:

Year:  2017        PMID: 28501693     DOI: 10.1016/j.neulet.2017.05.016

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  24 in total

1.  Necrostatin-1 ameliorates the pathogenesis of experimental autoimmune encephalomyelitis by suppressing apoptosis and necroptosis of oligodendrocyte precursor cells.

Authors:  Ying Wang; Li Guo; Jueqiong Wang; Wei Shi; Zhilun Xia; Bin Li
Journal:  Exp Ther Med       Date:  2019-09-13       Impact factor: 2.447

2.  Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke.

Authors:  Masanori Gomi Naito; Daichao Xu; Palak Amin; Jinwoo Lee; Huibing Wang; Wanjin Li; Michelle Kelliher; Manolis Pasparakis; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

3.  NLRP3 Inflammasome Is Involved in Q-VD-OPH Induced Necroptosis Following Cerebral Ischemia-Reperfusion Injury.

Authors:  Xue Teng; Weiwei Chen; Zhihan Liu; Tao Feng; Hui Li; Sheng Ding; Yonggang Chen; Ying Zhang; Xianping Tang; Deqin Geng
Journal:  Neurochem Res       Date:  2018-05-25       Impact factor: 3.996

4.  Anti-IL-23 exerted protective effects on cerebral ischemia-reperfusion injury through JAK2/STAT3 signaling pathway.

Authors:  Lichao Fan; Lichun Zhou
Journal:  Mol Biol Rep       Date:  2021-04-26       Impact factor: 2.316

Review 5.  Cell Death Mechanisms in Cerebral Ischemia-Reperfusion Injury.

Authors:  Qian Zhang; Meng Jia; YunFu Wang; Qun Wang; Jianping Wu
Journal:  Neurochem Res       Date:  2022-08-17       Impact factor: 4.414

6.  Combination of Emricasan with Ponatinib Synergistically Reduces Ischemia/Reperfusion Injury in Rat Brain Through Simultaneous Prevention of Apoptosis and Necroptosis.

Authors:  Jing Tian; Shu Guo; Heng Chen; Jing-Jie Peng; Miao-Miao Jia; Nian-Sheng Li; Xiao-Jie Zhang; Jie Yang; Xiu-Ju Luo; Jun Peng
Journal:  Transl Stroke Res       Date:  2017-11-04       Impact factor: 6.829

7.  Necrostatin-1 Against Sevoflurane-Induced Cognitive Dysfunction Involves Activation of BDNF/TrkB Pathway and Inhibition of Necroptosis in Aged Rats.

Authors:  Chunping Yin; Qi Zhang; Juan Zhao; Yanan Li; Jiaxu Yu; Wei Li; Qiujun Wang
Journal:  Neurochem Res       Date:  2022-01-18       Impact factor: 3.996

8.  Inhibition of necroptosis attenuates lung injury and improves survival in neonatal sepsis.

Authors:  Alexandra C Bolognese; Weng-Lang Yang; Laura W Hansen; Naomi-Liza Denning; Jeffrey M Nicastro; Gene F Coppa; Ping Wang
Journal:  Surgery       Date:  2018-04-27       Impact factor: 4.348

Review 9.  Cell Death and Neurodegeneration.

Authors:  Benjamin J Andreone; Martin Larhammar; Joseph W Lewcock
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-02-03       Impact factor: 10.005

Review 10.  Insight into Crosstalk between Ferroptosis and Necroptosis: Novel Therapeutics in Ischemic Stroke.

Authors:  Yue Zhou; Jun Liao; Zhigang Mei; Xun Liu; Jinwen Ge
Journal:  Oxid Med Cell Longev       Date:  2021-06-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.